EX-99.1 2 tm256785d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Waystar Reports Fourth Quarter and Fiscal Year 2024 Results

 

Fiscal year 2024 revenue of $944M, up 19% YoY

 

Q4 revenue growth of 18% year-over-year

 

Q4 net income of $19.1 million and non-GAAP net income of $52.1 million

 

Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY

 

Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY

 

Q4 net income margin of 8%; adjusted EBITDA margin of 41%

 

LEHI, Utah and LOUISVILLE, Ky., February 18, 2025 — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024.

 

“We are pleased to report strong results for the fourth quarter and full year 2024, exceeding expectations and reflecting the successful execution of our strategic priorities,” said Matt Hawkins, Chief Executive Officer of Waystar. “By leveraging the power of our cloud-based software platform, we have consistently delivered measurable return on investment for our clients.”

 

Hawkins continued, “Looking ahead, we expect to achieve solid revenue growth at scale, paired with compelling adjusted EBITDA margins, positioning us for continued success.”

 

Fourth Quarter 2024 Financial Highlights

 

·Revenue of $244.1 million, up 18% year-over-year
·Net income of $19.1 million, GAAP net income per share of $0.11, and net income margin of 8%
·Non-GAAP net income of $52.1 million and non-GAAP net income per diluted share of $0.29
·Adjusted EBITDA of $100.2 million and adjusted EBITDA margin of 41%
·Cash flow from operations of $65 million and unlevered free cash flow of $80 million

 

Key Metrics and Revenue Disaggregation

 

·1,203 clients contributed over $100,000 in LTM revenue, up 15% year-over-year
·Net revenue retention rate (NRR) of 110%

 

 

 

 

·Subscription revenue of $121.6 million, up 18% year-over-year
·Volume-based revenue of $121.2 million, up 19% year-over-year

 

Financial Outlook

 

As of February 18, 2025, Waystar provides the following guidance for its full fiscal year 2025.1

 

·Total revenue is expected to be between $1.0 billion and $1.016 billion
·Adjusted EBITDA is expected to be between $399 million and $407 million
·Non-GAAP net income is expected to be between $237 million and $243 million
·Diluted non-GAAP net income per share is expected to be between $1.29 and $1.32

 

Webcast Information

 

Waystar’s financial results will be discussed on a conference call scheduled at 8:30 a.m. Eastern Standard Time today, February 18, 2025. A live audio conference call will be available on Waystar's website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real time. This earnings release and the related Current Report on Form 8-K filed February 18, 2025 can be accessed on the Investor Relations page of the company’s website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission (“SEC”) filings, and public conference calls and webcasts.

 

 

1 We have not reconciled the forward-looking adjusted EBITDA, non- GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

 

 

 

 

Non-GAAP Financial Measures

 

To supplement the consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles (“GAAP”), this press release contains certain non-GAAP financial measures as defined below. We present non-GAAP financial measures as supplemental measures of financial performance that are not required by, or presented in accordance with, GAAP. We believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses adjusted EBITDA and adjusted EBITDA margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide.

 

Adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.

 

The following non-GAAP financial measures and key performance metrics are defined below:

 

Adjusted EBITDA and adjusted EBITDA Margin

 

We define adjusted EBITDA as net loss before interest expense, net income tax benefit, depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements, and IPO related costs. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.

 

 

 

 

Non-GAAP Net Income and Non-GAAP Net Income Per Share

 

We define non-GAAP net income as GAAP net income excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, IPO related costs, costs related to amended debt agreements and amortization of intangibles. We updated the definition of non-GAAP net income to include amortization of intangibles to align with a more common definition used by our peers. We have revised prior year disclosures to align with this updated definition. The tax effects of the adjustments are calculated using a management-estimated annual effective non-GAAP tax rate of 21%.

 

We define non-GAAP net income per share as non-GAAP net income (loss) divided by weighted-average shares used to compute net loss per share.

 

Unlevered Free Cash Flow

 

We define unlevered free cash flow as cash from operations plus cash interest expense less capital expenses.

 

Net Debt

 

We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents.

 

Adjusted Net Leverage Ratio

We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.

 

Key Performance Metrics

 

Net Revenue Retention Rate

 

Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.

 

Customer Count with >$100,000 of Revenue

 

We regularly monitor and review our count of clients who generate more than $100,000 of revenue.

 

 

 

 

Our count of clients who generate more than $100,000 of revenue is based on an accumulation of the amounts invoiced to clients over the preceding twelve months. The invoices for acquired clients are included starting in the first full calendar quarter after the date of acquisition.

 

Forward-Looking Statements

 

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar’s expectations relating to future operating results and financial position, including full year 2025, and future periods; the performance of our new product offerings; our industry and market opportunities, business strategy, goals, and expectations concerning our market position, future operations, margins and profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” “outlook,” the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2025.

 

 

 

 

The forward-looking statements contained in this press release are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients’ timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients’ and their vendors’ networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform; the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; our use of “open source” software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; healthcare laws and data privacy and security laws and regulations governing our processing of personal information; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; consumer protection laws and regulations; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of “Risk Factors” in the Company’s 10K filed with the Securities and Exchange Commission (the “SEC”) on February 18, 2025, our prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 7, 2024, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

 

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

 

 

 

 

About Waystar

 

Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar’s enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

 

 

 

 

Waystar

Consolidated Statements of Operations

(in thousands, except for share and per share data)

(unaudited)

 

   Three months ended
December 31,
   Twelve months ended
December 31,
 
   2024   2023   2024   2023 
Revenue   244,102    206,695    943,549    791,010 
Operating expenses                    
Cost of revenue (exclusive of depreciation and amortization expenses)   79,542    67,190    315,730    249,767 
Sales and marketing   38,990    30,946    156,935    124,437 
General and administrative   22,959    16,400    111,753    62,924 
Research and development   11,472    9,785    48,775    35,332 
Depreciation and amortization   37,996    44,686    186,631    176,467 
Total operating expenses   190,959    169,007    819,824    648,927 
Income from operations   53,143    37,688    123,725    142,083 
Other expense                    
Interest expense   (19,003)   (51,262)   (141,762)   (198,309)
Related party interest expense   (1,083)   (1,598)   (4,508)   (7,608)
Income/(loss) before income taxes   33,057    (15,172)   (22,545)   (63,834)
Income tax expense/(benefit)   13,978    (757)   (3,420)   (12,500)
Net income/(loss)   19,079    (14,415)   (19,125)   (51,334)
Net income/(loss) per share:                    
Basic   0.11    (0.12)   (0.13)   (0.42)
Diluted   0.11    (0.12)   (0.13)   (0.42)
Weighted-average shares outstanding:                    
Basic   172,526,776    121,679,113    149,915,839    121,675,430 
Diluted   179,112,559    121,679,113    149,915,839    121,675,430 

 

 

 

 

Waystar

Consolidated Balance Sheets

(in thousands, except for share and per share data)

 

   December 31, 2024   December 31, 2023 
Assets          
Current assets          
Cash and cash equivalents   182,133    35,580 
Restricted cash   22,449    9,848 
Accounts receivable, net of allowance of $5,885 at December 31, 2024 and $5,335 at December 31, 2023   145,235    126,089 
Income tax receivable   2,838    6,811 
Prepaid expenses   14,414    13,296 
Other current assets   3,972    30,426 
Total current assets   371,041    222,050 
Property, plant and equipment, net   46,731    61,259 
Operating lease right-of-use assets, net   10,820    10,353 
Intangible assets, net   1,039,049    1,186,936 
Goodwill   3,019,999    3,030,013 
Deferred costs   82,815    65,811 
Other long-term assets   6,549    6,552 
Total assets   4,577,004    4,582,974 
Liabilities and stockholders' equity          
Current liabilities          
Accounts payable   47,365    45,484 
Accrued compensation   31,589    23,286 
Aggregated funds payable   22,059    9,659 
Other accrued expenses   15,930    10,923 
Deferred revenue   10,527    10,935 
Current portion of long-term debt   11,311    17,454 
Related party current portion of long-term debt   357    529 
Current portion of operating lease liabilities   5,591    4,398 
Current portion of finance lease liabilities   904    821 
Total current liabilities   145,633    123,489 
Long-term liabilities          
Deferred tax liability   100,523    174,480 
Long-term debt, net, less current portion   1,185,411    2,134,920 
Related party long-term debt, net, less current portion   35,211    64,758 
Operating lease liabilities, net of current portion   13,133    14,278 
Finance lease liabilities, net of current portion   11,290    12,194 
Deferred revenue - LT   5,739    6,173 
Other long-term liabilities   278    2,750 
Total liabilities   1,497,218    2,533,042 
Commitments and contingencies (Note 20)          
Stockholders' equity          
Preferred stock $0.01 par value - 100,000,000 and zero shares authorized as of December 31, 2024 and December 31, 2023, respectively; zero shares issued or outstanding as of December 31, 2024 and December 31, 2023, respectively   -    - 
Common stock $0.01 par value - 2,500,000,000 and 227,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; 172,108,240 and 121,679,902 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively   1,722    1,217 
Additional paid-in capital   3,298,083    2,234,688 
Accumulated other comprehensive income (loss)   881    15,802 
Accumulated deficit   (220,900)   (201,775)
Total stockholders' equity   3,079,786    2,049,932 
Total liabilities and stockholders' equity   4,577,004    4,582,974 

 

 

 

 

Waystar

Consolidated Statements of Cash Flows

(in thousands)

 

   Twelve months ended December 31, 
   2024   2023 
Cash flows from operating activities          
Net loss   (19,125)   (51,334)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities          
Depreciation and amortization   186,631    176,467 
Stock-based compensation   54,437    8,848 
Provision for bad debt expense   2,669    2,419 
Loss on extinguishment of debt   20,611    393 
Deferred income taxes   (59,135)   (61,665)
Amortization of debt discount and issuance costs   3,946    10,471 
Other   (99)   485 
Changes in:          
Accounts receivable   (21,816)   (16,714)
Income tax refundable   3,973    (2,459)
Prepaid expenses and other current assets   (2,322)   (9,705)
Deferred costs   (16,497)   (14,189)
Other long-term assets   (472)   (1,664)
Accounts payable and accrued expenses   18,228    11,920 
Deferred revenue   (842)   (167)
Operating lease right-of-use assets and lease liabilities   (419)   (1,691)
Other long-term liabilities   -    45 
Net cash provided by operating activities   169,768    51,460 
Cash flows from investing activities          
Purchase of property and equipment and capitalization of internally developed software costs   (27,268)   (21,517)
Acquisitions, net of cash and cash equivalents acquired   -    (40,000)
Net cash used in investing activities   (27,268)   (61,517)
Cash flows from financing activities          
Change in aggregated funds liability   12,399    2,105 
Proceeds from equity offering, net of underwriting discounts   1,017,074    - 
Payments of third-party IPO issuance costs   (3,407)   - 
Repurchase of shares   (844)   (688)
Proceeds from exercise of common stock options   1,683    425 
Proceeds from issuances of debt, net of creditor fees   576,060    20,000 
Payments on debt   (1,584,080)   (37,983)
Third-party fees paid in connection with issuance of new debt   (1,410)   (219)
Finance lease liabilities paid   (821)   (791)
Net cash provided by (used in) financing activities   16,654    (17,151)
Increase in cash and cash equivalents during the period   159,154    (27,208)
Cash and cash equivalents and restricted cash - beginning of period   45,428    72,636 
Cash and cash equivalents and restricted cash - end of period   204,582    45,428 
Supplemental disclosures of cash flow information          
Interest paid   122,771    193,003 
Cash taxes paid (refunds received), net   51,100    51,449 
Non-cash investing and financing activities          
Fixed asset purchases in accounts payable   283    1,091 
Unpaid third-party IPO issuance costs   15    - 
Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement          
Balance sheet          
Cash and cash equivalents   182,133    35,580 
Restricted cash   22,449    9,848 
Total   204,582    45,428 

 

 

 

 

Waystar

Reconciliation of Adjusted EBITDA 

(in thousands)

(unaudited)  

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Net income/(loss)   19,079    (14,415)   (19,125)   (51,334)
Interest expense   20,086    52,860    146,270    205,917 
Income tax expense/(benefit)   13,978    (757)   (3,420)   (12,500)
Depreciation and amortization   37,996    44,686    186,631    176,467 
Stock-based compensation expense   7,037    2,343    54,437    8,848 
Acquisition and integration costs   163    711    859    3,947 
Costs related to amended debt agreements   1,262    393    14,138    393 
IPO related costs   26    423    2,140    1,977 
Other (a)   526    -    1,566    - 
Adjusted EBITDA   100,153    86,244    383,496    333,715 
Revenue   244,102    206,695    943,549    791,010 
Net income/(loss) margin   7.8%   -7.0%   -2.0%   -6.5%
Adjusted EBITDA margin   41.0%   41.7%   40.6%   42.2%

 

(a)Adjustments relate to additional lease costs due to the relocation of our Louisville office

 

 

 

 

Waystar

Reconciliation of Non-GAAP Operating Expenses

(in thousands)

(unaudited)

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Cost of revenue (exclusive of depreciation and amortization expenses)   79,542    67,190    315,730    249,767 
Less:                    
Stock-based compensation expense   (242)   (100)   (2,403)   (645)
Acquisition and integration costs   -    45    (31)   (13)
IPO related costs   -    -    (9)   - 
Other (a)   (33)   -    (33)   - 
Cost of revenue (exclusive of depreciation and amortization expenses), adjusted   79,267    67,135    313,254    249,109 
                     
Sales and marketing   38,990    30,946    156,935    124,437 
Less:                    
Stock-based compensation expense   (1,482)   (479)   (12,440)   (1,865)
Acquisition and integration costs   -    (17)   -    (66)
IPO related costs   (7)   (15)   (148)   (15)
Sales and marketing, adjusted   37,501    30,435    144,347    122,491 
                     
General and administrative   22,959    16,400    111,753    62,924 
Less:                    
Stock-based compensation expense   (4,245)   (1,405)   (31,288)   (5,035)
Acquisition and integration costs   (157)   (597)   (429)   (3,304)
Costs related to amended debt agreements   (1,262)   (393)   (14,138)   (393)
IPO related costs   (19)   (393)   (1,975)   (1,947)
Other (a)   (493)   -    (1,533)   - 
General and administrative, adjusted   16,783    13,612    62,390    52,245 
                     
Research and development   11,472    9,785    48,775    35,332 
Less:                    
Stock-based compensation expense   (1,068)   (359)   (8,306)   (1,303)
Acquisition and integration costs   (6)   (142)   (399)   (564)
IPO related costs   -    (15)   (8)   (15)
Research and development, adjusted   10,398    9,269    40,062    33,450 
                     
Depreciation and amortization   37,996    44,686    186,631    176,467 
Less:                    
Other (a)   (2,103)   -    (17,879)   - 
Intangible amortization (b)   (30,647)   (39,004)   (147,887)   (159,406)
Depreciation and amortization, adjusted   5,246    5,682    20,865    17,061 
                     
Income tax expense/(benefit)   13,978    (757)   (3,420)   (12,500)
Plus:                    
Tax effect of adjustments   8,770    9,004    50,170    36,660 
Income tax expense/(benefit), adjusted   22,748    8,247    46,750    24,160 

 

(a)Adjustments relate to additional lease costs and accelerated depreciation due to the relocation of our Louisville office
(b)Intangible amortization relates to acquisitions and therefore included in reconciliation.

 

 

 

 

Waystar

Reconciliation of Non-GAAP Net Income

(in thousands, except share and per share amounts)

(unaudited)  

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Net income/(loss)   19,079    (14,415)   (19,125)   (51,334)
Stock based compensation   7,037    2,343    54,437    8,848 
Acquisition and integration costs   163    711    859    3,947 
Costs related to amended debt agreements   1,262    393    14,138    393 
IPO related costs   26    423    2,140    1,977 
Other (a)   2,629    -    19,445    - 
Intangible amortization (b)   30,647    39,004    147,887    159,406 
Tax effect of adjustments   (8,770)   (9,004)   (50,170)   (36,660)
Non-GAAP net income/(loss)   52,073    19,455    169,611    86,577 
                     
Non-GAAP net income/(loss) per common share, basic   0.30    0.16    1.13    0.71 
Non-GAAP net income/(loss) per common share, diluted   0.29    0.15    1.09    0.68 
                     
Weighted average shares used in computing basic Non-GAAP net income/(loss) per share   172,526,776    121,679,113    149,915,839    121,675,430 
Weighted average shares used in computing diluted Non-GAAP net income/(loss) per share   179,112,559    127,303,675    155,677,094    126,888,989 

 

(a)Adjustments relate to additional lease costs and accelerated depreciation due to the relocation of our Louisville office
(b)Intangible amortization relates to acquisitions and therefore included in reconciliation.

 

Waystar

Reconciliation of Unlevered Free Cash Flow

(in thousands)

(unaudited)

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2024   2023   2024   2023 
Net cash provided by operating activities   64,770    11,456    169,768    51,460 
Interest paid   21,582    49,318    122,771    193,003 
Purchase of property and equipment and capitalization of internally developed software costs   (6,224)   (5,791)   (27,268)   (21,517)
Unlevered free cash flow   80,128    54,983    265,271    222,946 

 

 

 

 

Waystar

Reconciliation of Net Debt

(in thousands)

(unaudited) 

 

   December 31, 2024   December 31, 2023 
First lien term loan facility outstanding debt, current   11,668    17,983 
First lien term loan facility outstanding debt, net of current portion   1,151,878    1,712,833 
Second lien term loan facility outstanding debt   -    448,000 
Receivables facility outstanding debt   80,000    70,000 
Cash and cash equivalents   (182,133)   (35,580)
Net debt   1,061,413    2,213,236 
           
Trailing Twelve Months Adjusted EBITDA   383,496    333,715 
           
Adjusted Gross leverage ratio   3.2x   6.7x
Adjusted Net leverage ratio   2.8x   6.6x

 

Waystar

Reconciliation of Trailing Twelve Months (TTM) Adjusted EBITDA

(in thousands)

(unaudited)  

 

   Three Months Ended   TTM 
   December 31,   September 30,   June 30,   March 31,   December 31, 
   2024   2024   2024   2024   2024 
Net income/(loss)   19,079    5,413    (27,685)   (15,932)   (19,125)
Interest expense   20,086    18,459    50,541    57,184    146,270 
Income tax expense/(benefit)   13,978    3,274    (14,611)   (6,061)   (3,420)
Depreciation and amortization   37,996    60,185    44,276    44,174    186,631 
Stock-based compensation expense   7,037    7,903    36,969    2,528    54,437 
Acquisition and integration costs   163    188    206    302    859 
Costs related to amended debt agreements   1,262    106    2,368    10,402    14,138 
IPO related costs   26    109    1,841    164    2,140 
Other (a)   526    1,040    -    -    1,566 
Adjusted EBITDA   100,153    96,677    93,905    92,761    383,496 

 

(a)Adjustments relate to additional lease costs due to the relocation of our Louisville office

 

Media Contact

Kristin Lee

kristin.lee@waystar.com

 

Investor Contact

Sandy Draper

investors@waystar.com

502-238-9511